Mechanisms of allergen immunotherapy

Allergy and Clinical Immunology International

Volumn 16, Issue 2, 2004, Pages 65-69

  Akdis, Mübeccel ^a   Schmidt Weber, Carsten ^a   Jutel, Marek ^b   Akdis, Cezmi A ^a   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

IL 10; Specific immunotherapy; T reg cells; TGF ; Tolerance

Indexed keywords

ALLERGEN; ANTIGEN; BEE VENOM; CD4 ANTIGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; PEPTIDE; PHOSPHOLIPASE A2; POLLEN ANTIGEN; TETANUS TOXOID; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ANTIBODY PRODUCTION; ARTICLE; CYTOKINE RELEASE; EFFECTOR CELL; EX VIVO STUDY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MEMORY CELL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 1642523802     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.16.2.65     Document Type: Article

References (16)

1. Blaser K, Carballido JM, Faith A, Crameri R, Akdis CA. Determinants and mechanisms of human immune response to bee venom phospholipase A2. Int Arch Allergy Immunol 1998; 117:1-10
2. Carballido JM, Carballido-Perrig N, Torres G, Heusser CH, Blaser K. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: Cytokine patterns change in response to the antigen concentration. Eur J Immunol 1992; 22:1357-1363
3. Akdis CA, Blaser K. IL-10 induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy. FASEB J 1999; 13:603-609
4. Akdis CA, Blaser K. Mechanisms of interleukin-10 mediated immune suppression. Immunology 2001; 103:131-136
5. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K. Role of IL-10 in specific immunotherapy. J Clin Invest 1998; 102:98-106
6. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Müller U, Blaser K. Fpitope specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98:1676-1683
7. Akdis CA, Blaser K, Akdis M. Genes of tolerance. Allergy 2004; (in press)
8. REG cells and allergy: A question of balance and antigen-specificity. Nature Rev Immunol (Online) 2003; 3 http://www.nature.com/nri/focus/relymph/viewpoints/nri1047_r.html]
9. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-1214
10. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102:157-164
11. Carballido JM, Carballido-Perrig N, Kagi MK, Meloen RH, Wuthrich B, Heusser CH, Blaser K. T cell epitope specificity in human allergic and non-allergic subjects to bee venom phospholipase A2. J Immunol 1993; 150:3582-3591
12. Müller UR, Akdis CA, Fricker M, Akdis M, Bettens F, Blesken T, Blaser K. Successful immunotherapy with T cell epitope peptides of bee venom phospholipase A2 induces specific T cell anergy in bee sting allergic patients. J Allergy Clin Immunol 1998; 101:747-754
13. Carballido JM, Carballido-Perrig N, Oberli-Schrammli A, Heusser CH, Blaser K. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro. J Allergy Clin Immunol 1994; 93:758-767
14. Akdis CA, Joss A, Akdis M, Faith A, Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 2000; 14:1666-1669
15. Joss A, Akdis M, Faith A, Blaser K, Akdis CA. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 2000; 30:1683-1690
16. Kunzmann S, Wohlfahrt JG, Itoh S, Asao H, Komada M, ten-Dijke P, Akdis CA, Blaser K, Schmidt-Weber CB. SARA and Hgs attenuate susceptibility to TGF-β1-mediated T-cell suppression. FASEB J 2003; 17:194-202